Novel process for purifying heparan-n-sulfatase.

TN2025000054A1Undetermined Publication Date: 2026-10-01GC BIOPHARMA CORP +1

0 Cites 0 Cited by

Patent Information

Application Number: TN2025000054P0
Authority / Receiving Office: TN · TN
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-02-21
Publication Date: 2026-10-01

Application Information

Patent Timeline

21 Feb 2025

Application

TN2025000054P0

01 Oct 2026

Publication

TN2025000054A1

Inventors: KO, Kwanyoung; KIM, Dasom

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition of a high concentration of heparan N-sulfatase (H NS) with enhanced stability for CNS delivery and a pharmaceutical formulation comprising the same. The pharmaceutical composition and pharmaceutical formulation comprising the same according to the present invention have excellent formulation stability, such as a reduction in turbidity and a significant improvement in purity, which may be useful in enzyme replacement therapy (ERT) for the treatment of mucopolysaccharidosis type III.

Need to check novelty before this filing date? Find Prior Art